News and events

ENDPOINTS NEWS: Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks

NewBiologix Launches Xcell™ to Accelerate, Optimize, and Scale Gene and Cell Therapy Production

NewBiologix Abstracts Selected for Two Poster Presentations at European Society of Gene & Cell Therapy 2024 Congress

Revolutionizing Gene Therapy with Igor Fisch CEO of NewBiologix

NewBiologix Launches Proprietary HEK293 Cell Line for the Expression of Viral Vectors Used in Gene Therapy

NewBiologix Sponsors Charity Gala 2024 in San Diego During BIO International Convention

NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries

NewBiologix Licenses Florabio’s HEK293 Cell Line for the Generation of Novel and Proprietary Cell Lines for the Stable Expression of rAAVs used in Gene Therapy

NewBiologix in the Biopôle Review – 2023 Edition: Secrets of a serial entrepreneur